Biopharmaceutical developers should introduce risk-based, phase-appropriate characterization strategies for quality control ...
Solstice Advanced Materials ("Solstice" or the "Company") and Element Solutions ("Element") today announced that they have entered into a definitive agreement for Solstice to acquire Element in a ...
Fifteen years after its inception, Basel III is fragmenting into three distinct bank regulatory models across the EU, UK, and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results